Acupuncture As an Adjunct to Lifestyle Interventions for Weight Loss in Simple Obesity: A Systematic Review and Meta-Analysis

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2024 Nov 25

PMID 39582784

Authors

Xinyu Zhao

Yang Wang

Xiaoyi Li

Peiqun Hu

Xiong-Fei Pan

Benxiang He

Yunlu Liu

Yushi Hu

Tianmin Zhu

Affiliations

Soon will be listed here.

Abstract

Objective: This study aims to evaluate the efficacy of acupuncture as an adjunct to lifestyle interventions on weight loss in simple obesity.

Methods: Potentially eligible studies that assessed anthropometric outcomes as well as glucose and lipid metabolism following acupuncture combined with lifestyle interventions in simple obesity patients were searched from eight databases from inception to October 2023. All analyses were performed using the Review Manager software v5.4 and Stata software v17.0.

Results: Herein, 25 randomized controlled trials (RCTs) involving 2018 patients were included. Generally, acupuncture combined with lifestyle interventions outperformed lifestyle interventions alone in terms of body weight (MD = -4.73, 95% CI [-6.32, -3.13], < 0.00001), body mass index (BMI) (MD = -2.11, 95% CI [-2.75, -1.48], < 0.00001), waist circumference (WC) (MD = -4.96, 95% CI [-6.89, -3.03], < 0.00001), body fat percentage (BF %) (MD = -2.61, 95% CI [-4,51, -0.71], = 0.007), fasting plasma glucose (FPG) (SMD = -0.66, 95% CI [-1.02, -0.31], = 0.0002), fasting serum insulin (FINS) (SMD = -1.12, 95% CI [-1.44, -0.81], < 0.00001), homeostasis model assessment-insulin resistance (HOMA-IR) (MD = -1.22, 95% CI [-1.50, -0.94], < 0.00001), total cholesterol (TC) (SMD = -1.14, 95% CI [-1.83, -0.45], = 0.001), triglyceride (TG) (SMD = -1.31, 95% CI [-2.07, -0.56], = 0.0006), and low-density lipoprotein cholesterol (LDL-C) (SMD = -1.81, 95% CI [-3.11, -0.51], = 0.006). Subgroup analysis based on three subgroup variables (types of acupuncture and lifestyle interventions as well as treatment durations) could partially explain the heterogeneity of the results.

Conclusion: Acupuncture demonstrated an enhancing effect on the benefits of lifestyle interventions for weight loss in patients with simple obesity, including reducing body weight and improving glucose and lipid metabolism. This finding suggests its potential value as a complementary therapy alongside lifestyle interventions in a clinical setting. However, further validation with rigorously designed and high-quality RCTs is still needed in the future.

References

Wang L, Wang B, Gasek N, Zhou Y, Cohn R, Martin D . Targeting p21 highly expressing cells in adipose tissue alleviates insulin resistance in obesity. Cell Metab. 2021; 34(1):75-89.e8. PMC: 8732323. DOI: 10.1016/j.cmet.2021.11.002. View

Fang S, Wang M, Zheng Y, Zhou S, Ji G . Acupuncture and Lifestyle Modification Treatment for Obesity: A Meta-Analysis. Am J Chin Med. 2017; 45(2):239-254. DOI: 10.1142/S0192415X1750015X. View

Valenzuela P, Carrera-Bastos P, Castillo-Garcia A, Lieberman D, Santos-Lozano A, Lucia A . Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol. 2023; 20(7):475-494. DOI: 10.1038/s41569-023-00847-5. View

Su X, Peng D . The exchangeable apolipoproteins in lipid metabolism and obesity. Clin Chim Acta. 2020; 503:128-135. DOI: 10.1016/j.cca.2020.01.015. View

Liang F, Chen R, Nakagawa A, Nishizawa M, Tsuda S, Wang H . Low-Frequency Electroacupuncture Improves Insulin Sensitivity in Obese Diabetic Mice through Activation of SIRT1/PGC-1α in Skeletal Muscle. Evid Based Complement Alternat Med. 2010; 2011:735297. PMC: 2964507. DOI: 10.1155/2011/735297. View

Gong M, Cao C, Chen F, Li Q, Bi X, Sun Y . Electroacupuncture attenuates hepatic lipid accumulation via AMP-activated protein kinase (AMPK) activation in obese rats. Acupunct Med. 2015; 34(3):209-14. DOI: 10.1136/acupmed-2015-010798. View

Wadden T, Tronieri J, Butryn M . Lifestyle modification approaches for the treatment of obesity in adults. Am Psychol. 2020; 75(2):235-251. PMC: 7027681. DOI: 10.1037/amp0000517. View

Yin Y, Zhao Q, Li S, Jiang H, Yin C, Chen H . Efficacy of acupuncture and moxibustion therapy for simple obesity in adults: A meta-analysis of randomized controlled trials. Medicine (Baltimore). 2022; 101(43):e31148. PMC: 9622642. DOI: 10.1097/MD.0000000000031148. View

Wang M, Liu W, Ge J, Liu S . The immunomodulatory mechanisms for acupuncture practice. Front Immunol. 2023; 14:1147718. PMC: 10117649. DOI: 10.3389/fimmu.2023.1147718. View

10.

Norman G, Sloan J, Wyrwich K . Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003; 41(5):582-92. DOI: 10.1097/01.MLR.0000062554.74615.4C. View

11.

Pan X, Wang L, Pan A . Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021; 9(6):373-392. DOI: 10.1016/S2213-8587(21)00045-0. View

12.

Song A, Zhang Y, Chen R, Liang F . Is Acupuncture Effective for Improving Insulin Resistance? A Systematic Review and Meta-analysis. Curr Med Sci. 2018; 38(6):1109-1116. DOI: 10.1007/s11596-018-1991-1. View

13.

Yang H, Xiao Z, Yin Z, Yu Z, Liu J, Xiao Y . Efficacy and safety of acupuncture for polycystic ovary syndrome: An overview of systematic reviews. J Integr Med. 2023; 21(2):136-148. DOI: 10.1016/j.joim.2022.12.002. View

14.

Gong M, Wang X, Mao Z, Shao Q, Xiang X, Xu B . Effect of electroacupuncture on leptin resistance in rats with diet-induced obesity. Am J Chin Med. 2012; 40(3):511-20. DOI: 10.1142/S0192415X12500395. View

15.

Kesztyus D, Erhardt J, Schonsteiner D, Kesztyus T . Therapeutic Treatment for Abdominal Obesity in Adults. Dtsch Arztebl Int. 2018; 115(29-30):487-493. PMC: 6121087. DOI: 10.3238/arztebl.2018.0487. View

16.

Zeng Q, Li N, Pan X, Chen L, Pan A . Clinical management and treatment of obesity in China. Lancet Diabetes Endocrinol. 2021; 9(6):393-405. DOI: 10.1016/S2213-8587(21)00047-4. View

17.

Zatterale F, Longo M, Naderi J, Raciti G, Desiderio A, Miele C . Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front Physiol. 2020; 10:1607. PMC: 7000657. DOI: 10.3389/fphys.2019.01607. View

18.

Shao J, Li C, Bai L, Ni X, Ge S, Zhang J . Recent evidence in support of traditional chinese medicine to restore normal leptin function in simple obesity. Heliyon. 2022; 8(5):e09482. PMC: 9127329. DOI: 10.1016/j.heliyon.2022.e09482. View

19.

Boutari C, Mantzoros C . A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022; 133:155217. PMC: 9107388. DOI: 10.1016/j.metabol.2022.155217. View

20.

Guo F, Garvey W . Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release. Diabetes Care. 2017; 40(7):856-862. PMC: 5481985. DOI: 10.2337/dc17-0088. View